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The possible link with cognitive changes caused by arter-ial microembolization during cardiopulmonary bypass(CPB) drives cardiac surgery toward off-pump proce-dures. One of these CPB effects is blood trauma. CPB
indeed causes hemolysis, but in terms of erythrocyte flow function,
some conflicting results exist.1,2 With regard to CPB, the focus of
science has been on leukocytes and systemic inflammatory
response,3,4 whereas the capillary flow function of blood remains
an unexplored field. Of great interest are new observations about
fat deposits in brain capillaries versus the reinfusion of pericardial
suction blood.5 The possible role of activated leukocytes and
platelets has also been discussed.6 We aimed at investigating the
embolic potential of the different blood subcomponents. This was
accomplished by using an in vitro narrow-pore flow model with
diameter approximating the size of human capillaries.
Materials and Methods
Ten elective CPB cases were selected at random: 7 coronary artery
bypass grafting, 1 aortic valve replacement, and 2 combined pro-
cedures. Blood was sampled before CPB (before anesthetic induc-
tion), 5 minutes after CPB onset, and at the end of CPB. The CPB
was of standard design: crystalloid antegrade cardioplegia, moder-
ate hypothermia, no arterial filters, and recirculation of
unprocessed pericardial suction blood. Of a 15-mL blood sample,
250 µL was used to determine differential blood cell counts, and
the remaining was centrifuged (5 minutes at 1500g) for plasma
removal. Plasma was saved for flow analysis (see below) and for
plasma-free hemoglobin. The blood cells were then prepared to
express its subcomponents. With the buffy coat remaining, the rest
of the plasma was removed by means of centrifugation and wash-
ing in 2 cycles (Krebs-Ringer-HEPES buffer [KRH]). One third of
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this blood was collected as sample A, with leukocytes remaining.
The remaining blood was recentrifuged, with removal of the buffy
coat, and resuspended as sample B. Sample B is the traditional
method of leukocyte reduction and was used in historic CPB inves-
tigations. Half of sample B was filtered through a leukocyte-elim-
inating filter7 and referred to as sample C, with only erythrocytes
remaining. The narrow-pore flow characteristics of these samples
and the plasma were measured with the KGE flowmeter
(ESTRAB, Umeå, Sweden).8 This computer-assisted system with
pneumatic valve control is used to measure the flow rate at high
temporal resolution by means of communication with a digital bal-
ance. Polycarbonate membranes with 5-µm capillaries were used.
The flow curves were divided by means of blank filtration to
express relative flow and with linear regression to find the initial
filtration rate (IFR) and the capillary clogging slope (CS). Narrow-
pore filtrating of blood is a widely accepted method to simulate
capillary flow with many clinical implications.9 Paired and
unpaired Student t tests were used, and changes were verified by
means of analysis of variance testing.
Results
Minor hemolysis occurred, corresponding to 0.6% of the circulat-
ing erythrocytes at the end of CPB. The erythrocyte particle con-
centration dropped at CPB onset as a result of priming and provid-
ed correction for hemodilution (Table 1). Mainly the neutrophilic
granulocytes increased during CPB. In Figure 1 the flow curves of
the different blood subcomponents are displayed (ie, plasma,
washed and resuspended whole blood cells, blood cells after tradi-
tional buffy-coat removal, and erythrocytes only). The plasma flow
suggested that the CPB priming reduced the capillary relative vis-
cosity (increased IFR, P < .001). However, plasma flow then
decreased (in terms of both IFR and CS, P < .05) with further CPB.
This response indicated particle contamination because the
hemodilution remained constant. The pattern of whole blood cells
suggested deteriorated capillary flow properties at the end of CPB
(sample A; Figure 1, B; IFR, P < .01). This pattern remained when
the traditional leukocyte buffy-coat removal was used (sample B,
P < .05). However, when all leukocytes were eliminated, the dif-
ference disappeared (sample C). The IFR and CS values are indi-
cated in Table 2.
Discussion
Our data suggest that CPB indeed does impair the narrow-pore
flow characteristics of blood and may therefore contribute to
microembolization and CPB-related cognitive disorders. This was
seen with resuspended whole blood cells and occurred at the end
of CPB. The impaired capillary flow remained when the buffy coat
was removed. In historic data this was misinterpreted as an eryth-
rocyte-related change.1 In our preparation the buffy-coat aspiration
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only removed 55% of the leukocytes, a problem known from the
literature.7 When all leukocytes were eliminated with an absorbing
filter,7 there was no detected difference with CPB. The decrease in
capillary flow hides 2 mechanisms: an increase in leukocyte count
and possible leukocyte activation. Another concern was the plas-
ma-flow pattern at the end of CPB, with changes in both IFR (indi-
cating relative capillary viscosity) and slope (clogging particles).
These particles are not blood cells but instead represent low-den-
sity contamination, such as fat cells, platelet aggregates, or cell
debris. The model was very sensitive, and the 10 random CPB
Figure 1. Relative flow of plasma and 5% hematocrit blood resuspensions as a function of time by using 5-µm polycarbon-
ate membranes: A, plasma flow curve; B, the entire pool of washed whole blood cells was resuspended in KRH; C, the buffy
coat was removed, and the remaining blood cells were washed and resuspended in KRH; D, the buffy coat was removed,
and the blood was filtrated through a leukocyte-eliminating filter, followed by washing and resuspension of the erythro-
cytes in KRH. Values are means ± SEM (n = 10). Error bars are given at 5-period intervals.
A B
C D
TABLE 1. Blood and cellular changes caused by CPB
(1) Before CPB P value (2) 5-min CPB P value (3) End of CPB P value
Parameter (unit) (mean ± SEM) (2 vs 1) (mean ± SEM) (3 vs 2) (mean ± SEM) (3 vs 1)
Absolute values
p-Hb (mg/L) 36 ± 4 .05 79 ± 19 <.01 501 ± 104 <.01
Erythrocytes (1012/L) 4.34 ± 0.13 <.001 2.78 ± 0.12 NS 2.92 ± 0.12 <.001
Leukocytes (109/L) 5.60 ± 0.57 <.01 3.89 ± 0.36 <.01 8.14 ± 0.81 <.05
Neutrophils (109/L) 3.14 ± 0.32 <.01 1.90 ± 0.17 <.001 5.78 ± 0.80 <.05
Lymphocytes (109/L) 1.67 ± 0.20 NS 1.40 ± 0.12 <.01 1.71 ± 0.13 NS
Monocytes (109/L) 0.41 ± 0.05 NS 0.31 ± 0.05 NS 0.41 ± 0.08 NS
Eosinophils (109/L) 0.30 ± 0.07 NS 0.18 ± 0.04 NS 0.20 ± 0.05 NS
Basophils (109/L) 0.06 ± 0.02 NS 0.04 ± 0.01 NS 0.05 ± 0.02 NS
Values corrected for hemodilution
p-Hb (mg/L) 36 ± 4 <.05 133 ± 30 <.01 746 ± 154 <.01
Leukocytes (109/L) 5.60 ± 0.57 NS 5.79 ± 0.49 <.001 12.03 ± 1.04 <.001
Neutrophils (109/L) 3.14 ± 0.32 NS 2.92 ± 0.24 <.001 8.49 ± 1.05 <.01
Lymphocytes (109/L) 1.67 ± 0.20 <.05 2.14 ± 0.15 <.01 2.56 ± 0.20 <.01
Monocytes (109/L) 0.41 ± 0.05 NS 0.48 ± 0.08 NS 0.61 ± 0.12 NS
Eosinophils (109/L) 0.30 ± 0.07 NS 0.26 ± 0.06 NS 0.30 ± 0.07 NS
Basophils (109/L) 0.06 ± 0.02 NS 0.06 ± 0.02 NS 0.08 ± 0.03 NS
The upper panel of the table denotes absolute values, whereas in the lower panel the counts were adjusted for hemodilution at CPB onset (see “Materials
and Methods” section). Values are given as means ± SEM (n = 10). p-Hb, Plasma hemoglobin; NS, not significant.
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cases had significant outcomes. The experimental model is not
sensitive to platelets, erythrocyte aggregation does not occur
because the sample was free from plasma, and lysed cells were
removed by washing.
Blauth and coworkers10 demonstrated vessel occlusion in the
retina during CPB by using fluorescein retinal angiography. It is
possible that these embolic particles would become trapped in our
model. The model may provide useful information for in vitro mon-
itoring of capillary blood function during CPB. Of particular inter-
est is arterial-line filters and processing of pericardial suction blood.
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TABLE 2. Narrow-pore flow characteristics before and during CPB
(1) Before CPB P value (2) 5-min CPB P value (3) End of CPB P value
Suspension (mean ± SEM) (2 vs 1) (mean ± SEM) (3 vs 2) (mean ± SEM) (3 vs 1)
IFR (% of KRH blank)
Plasma 53.1 ± 3.6 <.001 77.0 ± 4.1 <.05 66.0 ± 2.1 <.01
(A) Leukocytes remaining 50.3 ± 1.6 NS 51.3 ± 2.3 <.01 37.4 ± 2.0 <.01
P value (A vs B) <.05 NS <.05
(B) Buffy coat removed 57.6 ± 2.3 NS 57.8 ± 2.5 <.05 47.9 ± 2.9 <.05
P value (B vs C) <.01 <.05 <.001
(C) Erythrocytes only 69.0 ± 2.0 NS 66.8 ± 1.5 NS 68.2 ± 2.0 NS
CS (% of KRH blank/s)
Plasma –3.09 ± 0.62 NS –2.77 ± 0.57 <.05 –3.86 ± 0.48 NS
(A) Leukocytes remaining –4.13 ± 1.00 NS –5.30 ± 0.70 NS –5.86 ± 0.62 NS
P value (A vs B) NS NS NS
(B) Buffy coat removed –3.75 ± 0.61 NS –4.51 ± 0.57 <.05 –5.83 ± 0.56 <.01
P value (B vs C) <.001 <.01 <.001
(C) Erythrocytes only –0.89 ± 0.16 NS –0.93 ± 0.72 NS –1.72 ± 0.41 NS
IFR and CS were calculated for the different CPB groups and blood preparations, as described in the legend to Figure 1. IFR and CS were derived by means
of linear regression of the individual relative filtration curves (blood flow vs KRH blank) between 1.2 and 5 seconds. Values are means ± SEM (n = 10). NS,
Not significant.
